Literature DB >> 27935657

Profile and reintegration experience of Ebola survivors in Guinea: a cross-sectional study.

Alexandre Delamou1,2,3, Bienvenu Salim Camara2, Jean Pe Kolie4, Achille Diona Guemou4, Nyankoye Yves Haba5, Shannon Marquez6, Abdoul Habib Beavogui2, Therese Delvaux3, Johan van Griensven3.   

Abstract

OBJECTIVE: To describe the experience of Guinean Ebola virus disease (EVD) survivors in Guinea, up to ten months after discharge from the Ebola treatment unit.
METHODS: Cross-sectional study using a standardised semistructured questionnaire among survivors from Conakry and Coyah districts in 2015 in Guinea. We used proportions, mean (standard deviation) and median (interquartile range) to summarise the variables. The McNemar chi-square test was used to compare proportions.
RESULTS: The 121 EVD survivors interviewed had a median reintegration time from discharge of 18 weeks (IQR: 14-32 weeks). Most survivors were aged 15-44 years (87.6%) with secondary to higher level of education (68.6%), and 25.6% were healthcare workers. The majority reported a lower socio-economic status (90%), a less favourable work situation (79%) and psychological status (60%). About 31% reported physical health problems. Most survivors reported lower levels of reintegration with friends and at work place (72%) and lower acceptance by others in general (71%) in the period after the EVD as compared to the period before the EVD. Only 55 survivors (45.5%) were involved in one or more activities of the EVD response: participation in clinical studies on the EVD (44 survivors, 36.4%), community sensitisation (28 survivors, 23.1%) or work in Ebola treatment and/or transit centres (23 survivors, 21.7%).
CONCLUSION: There is a need for a long-term follow-up of EVD survivors in Guinea and more efforts to support their social, professional and economic reintegration, especially in rural areas.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  Ebola virus disease; Guinea; West Africa; reintegration; survivors

Mesh:

Year:  2017        PMID: 27935657     DOI: 10.1111/tmi.12825

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  6 in total

1.  The symbolic violence of 'outbreak': A mixed methods, quasi-experimental impact evaluation of social protection on Ebola survivor wellbeing.

Authors:  Eugene T Richardson; J Daniel Kelly; Osman Sesay; Michael D Drasher; Ishaan K Desai; Raphael Frankfurter; Paul E Farmer; Mohamed Bailor Barrie
Journal:  Soc Sci Med       Date:  2017-11-11       Impact factor: 4.634

2.  Human Rights in the Fourth Decade of the HIV/AIDS Response: An Inspiring Legacy and Urgent Imperative.

Authors:  Jamie Enoch; Peter Piot
Journal:  Health Hum Rights       Date:  2017-12

3.  "We are survivors and not a virus:" Content analysis of media reporting on Ebola survivors in Liberia.

Authors:  Elisabeth Anne-Sophie Mayrhuber; Thomas Niederkrotenthaler; Ruth Kutalek
Journal:  PLoS Negl Trop Dis       Date:  2017-08-24

4.  An assessment of Ebola-related stigma and its association with informal healthcare utilisation among Ebola survivors in Sierra Leone: a cross-sectional study.

Authors:  Peter Bai James; Jonathan Wardle; Amie Steel; Jon Adams
Journal:  BMC Public Health       Date:  2020-02-05       Impact factor: 3.295

5.  Health-related quality of life among Ebola survivors in Sierra Leone: the role of socio-demographic, health-related and psycho-social factors.

Authors:  Peter Bai James; Jon Wardle; Razak M Gyasi; Amie Steel; Jon Adams; John Alimamy Kabba; Abdulai Jawo Bah; Michael Lahai; Eugene B Conteh
Journal:  Health Qual Life Outcomes       Date:  2022-01-15       Impact factor: 3.186

6.  Stigma and Ebola survivorship in Liberia: Results from a longitudinal cohort study.

Authors:  Luc Overholt; David Alain Wohl; William A Fischer; Daniel Westreich; Sam Tozay; Edwina Reeves; Korto Pewu; David Adjasso; David Hoover; Carson Merenbloom; Harrietta Johnson; Gerald Williams; Tonia Conneh; Joseph Diggs; Alexandria Buller; Darrius McMillian; Darrel Hawks; Karine Dube; Jerry Brown
Journal:  PLoS One       Date:  2018-11-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.